期刊文献+

ⅢA期N_2非小细胞肺癌术后放疗疗效及预后因素分析 被引量:4

Analysis of postoperative radiotherapy effect in the treatment of patients with N_2 non-small cell lung cancer at ⅢA period and its prognostic factors
下载PDF
导出
摘要 目的探讨ⅢA期N2非小细胞肺癌术(NSCLC)术后放疗疗效及其预后影响因素。方法收集确诊的195例ⅢA期N2NSCLC术后放疗患者资料,以5年生存情况作为预后指标。结果ⅢA期N2NSCLC1年、3年、5年生存率分别为58.5%、29.7%、19.0%;多因素COX回归结果显示,影响N2期预后的独立因素包括肿瘤体积(OR=2.840)、T分级(OR=1.923)、N2转移组数(OR=2.672)为危险因素,而N2包膜完整性(OR=0.316)和放疗剂量(OR=0.270)为保护因素。结论ⅢA期N2NSCLC患者术后5年生存率较低,预后较差;肿瘤体积越大、T分级越高、N2淋巴结转移组数越多、N2包膜不完整、术后放疗剂量越低,是N2NSCLC期术后预后的独立危险因素。 Objective To explore the curative effect and prognostic factors of radiotherapy in the treatment of patients with Nz non-small cell lung cancer (NSCLC) at ⅢA period. Methods The clinical data of 195 patients with N2 NSCLC were retrospectively ana- lyzed, and 5-year survival was considered as the prognostic index. Results The survival rates of I year, 3 years and 5 years survival rates were respectively 58.5%, 29.7% and 19.0%. The results of multiple factors COX regression showed that the independent risk factors in- eluded gross tumor volume ( OR = 2. 840) , T grades ( OR = 1. 923 ) , and N2 metastasis groups ( OR = 2. 672). Nz amieula integrity ( OR = 0. 316) and radiotherapy dose ( OR = 0. 270) were protective factors. Conclusion The 5-year survival rate is a little lower in patients with Nz NSCLC with poor prognosis. The independent risk factors include gross tumor volume, high T-grade, Nz metastasis groups, N2 amieula imperfect and low radiation dose.
出处 《临床肺科杂志》 2013年第6期1100-1102,共3页 Journal of Clinical Pulmonary Medicine
关键词 非小细胞肺癌 N2期 术后放疗 预后 影响因素 non-small cell lung cancer (NSCLC) N2 stage postoperative radiotherapy prognosis influence factors
  • 相关文献

参考文献9

  • 1Goya T,Asamura H,Yoshimura H,et al. Prognosis of 6644 resec-ted nonsmall cell lung cancers in Japan: a Japanese lung cancer reg-istry study[ J]. Lung Cancer, 2005,51 (2) : 227 -234.
  • 2窦学军,刘树库,陈肖嘉,白连启,许绍发,闫东杰,龚昌帆.外科治疗III_A期N_2非小细胞肺癌的预后分析及临床意义[J].中华胸心血管外科杂志,2006,22(2):105-107. 被引量:18
  • 3Muehling B, Wehrmann C,Oberhuber A,et al. Comparison of clin-ical and surgical-pathological staging in HI A non-small ceil lungcancer patients[ J]. Ann Surg Oncol,2012,19(1) :89 - 93.
  • 4Thomas PA. Stage IE A N2 non-small-cell lung ecancer: currantconotroversles in onmbined-modality therapy [ J ]. Eur J Cardiutho-rae Surg, 2009,36(3) : 431 -432.
  • 5PORT Meta-analysis Trialists Group. Postoperative radiotherapy fornon-smMl cell lung cancer [ J ]. Cochrane Database Syst Rev,2005, 11(2) : 2142.
  • 6Okawara G, Ung YC, Markman BR, et al. Postoperative radiother-apy in stage H or IDA completely resected non-small cell lung canc-er asystematic review and practice guideline [ J ]. Lung Cancer,2004,44(1) ; 1 -11.
  • 7Lally BE, Zelterman D, Colasanto JM , et al. Postoperative radio-therapy for stage II or ID non-small-celi lung cancer using the sur-veillance ,epidemiology, and end results database[ J ]. J Clin On-ool, 2006,24(19) : 2998 -3006.
  • 8傅于捷,梁而慷,唐健,孙志勇,曹子昂.外科治疗N2非小细胞肺癌预后的多因素分析[J].河北医药,2009,31(19):2580-2581. 被引量:3
  • 9Bradley JD, Leumwananounthachai N, Purdy JA, et al. Crosstumor volume critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung car-cinoma [J]. Int J Radiat Oncol Biol Phys,2002, 52( 1) : 49 - 59.

二级参考文献21

  • 1赵坚,罗清泉.非小细胞肺癌N_2淋巴结转移临床研究[J].实用医技杂志,2008,15(14):1854-1856. 被引量:3
  • 2周清华.N2非小细胞肺癌外科治疗进展[J].中国肺癌杂志,2008,11(5):611-614. 被引量:8
  • 3周清华,王瑾,许峰.2005年美国国家综合癌症网(NCCN)非小细胞肺癌临床指南[J].中国肺癌杂志,2005,8(4):332-346. 被引量:75
  • 4Ohta Y,Shimizu Y,Minato H,et al.Results of initial operations in non-small cell lung cancer patients with single-level N2 disease.Ann Thorac Surg,2006,81:427-433.
  • 5Casali C,Stefani A,Natali P,et al.Prognostic factors in surgically resected N2 non-small cell lung cancer:the importance of patterns of mediastinal lymph nodes metastases.Eur Cardiothorac Surg,2008,28:33-38.
  • 6Melek H,Gunluolu MZ,Demir A,et al.Role of positron emission tomograghy in mediastinal lymphatic staging of non-small cell lung cancer.Eur J Cardiothorac Surg,2008,33:294-299.
  • 7Benoit L,Anusca A,Ortega-Deballon P,et al.Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small cell lung carcinoma.Eur J Surg Oncol,2006,32:583-587.
  • 8Vansteenkiste JF,De Leyn PR,Deneffe GJ,et al.Clinical prognostic factors in surgically treated stage ⅢA N2 non small cell lung cancer:analysis of the literature.Lung Cancer,1998,19:3-13.
  • 9Martini N,Flehinger BJ,Zaman MB,et al.Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases.Ann Surg,1983,198:386-397.
  • 10Fabrice A,Grunenwald D,Pignon JP,et al.Survival of patients with resected N2 non-small-cell lung cancer:evidence for a subclassification and implications.J Clin Oncol,2000,18:2981 -2989.

共引文献18

同被引文献37

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部